TGA Approval

EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle (405862)

ARTG ID

405862

ARTG Name

EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle

Sponsor

Bayer Australia Ltd

ARTG Date

June 14, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-02075-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02041-1

Ingredient Name

Aflibercept

Empowering clinical research with data-driven insights and AI-powered tools.

EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle (405862) - TGA 批准文号 | MedPath